TrialDrugs in R&D2023

A Randomised Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Palovarotene Ophthalmic Solution.

William J Foster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.